Publications by authors named "Ingeborg van Leeuwen"

Claim this Profile
B
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re-emergence of syphilis and HIV pre-exposure prophylaxis use.
Franke A Quee, Ed Slot, Ingeborg van Leeuwen, Ralph Brands, Eric J F Franssen

Transfusion· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Modulation of p53 C-Terminal Acetylation by Mdm2, p14ARF, and Cytoplasmic SirT2.
Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, Anna R McCarthy, Marijke C C Sachweh

Mol Cancer Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Marcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, Su Chu, Alan R Healy

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology.
Marcus J G W Ladds, Gergana Popova, Andrés Pastor-Fernández, Srinivasaraghavan Kannan, Ingeborg M M van Leeuwen

J Biol Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib.
Marcus J G W Ladds, Andrés Pastor-Fernández, Gergana Popova, Ingeborg M M van Leeuwen, Kai Er Eng

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Marcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, Su Chu, Alan R Healy

Nat Commun· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipids Shape the Electron Acceptor-Binding Site of the Peripheral Membrane Protein Dihydroorotate Dehydrogenase.
Joana Costeira-Paulo, Joseph Gault, Gergana Popova, Marcus J G W Ladds, Ingeborg M M van Leeuwen

Cell Chem Biol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.
Marcus J G W Ladds, Ingeborg M M van Leeuwen, Catherine J Drummond, Su Chu, Alan R Healy

Nat Commun· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner.
Anna R McCarthy, Marijke C C Sachweh, Maureen Higgins, Johanna Campbell, Catherine J Drummond, Ingeborg M M van Leeuwen

Mol Cancer Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.
Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, Anna R McCarthy, Marijke C C Sachweh

Mol Cancer Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclotherapy: opening a therapeutic window in cancer treatment.
Ingeborg M M van Leeuwen

Oncotarget· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.
Ingeborg M M van Leeuwen, Bhavya Rao, Marijke C C Sachweh, Sonia Laín

Cell Cycle· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-specific signatures for small-molecule p53 activators.
Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, Christopher J Brown, Anna R McCarthy

Cell Cycle· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological manipulation of the cell cycle and metabolism to protect normal tissues against conventional anticancer drugs.
Ingeborg M M van Leeuwen, Sonia Laín

Oncotarget· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic energy budget approaches for modelling organismal ageing.
Ingeborg M M van Leeuwen, Julio Vera, Olaf Wolkenhauer

Philos Trans R Soc Lond B Biol Sci· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.
Bhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, Johanna Campbell, Alastair M Thompson

Oncotarget· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems biologists seek fuller integration of systems biology approaches in new cancer research programs.
Olaf Wolkenhauer, Charles Auffray, Simone Baltrusch, Nils Blüthgen, Helen Byrne, Ingeborg van Leeuwen

Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirtuins and p53.
Ingeborg van Leeuwen, Sonia Lain

Adv Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells.
Ingeborg M M van Leeuwen, Helen M Byrne, Oliver E Jensen, John R King

J Theor Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a multiscale model of colorectal cancer.
Ingeborg M M van Leeuwen, Carina M Edwards, Mohammad Ilyas, Helen M Byrne

World J Gastroenterol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling microbial adaptation to changing availability of substrates.
Bernd W Brandt, Fleur D L Kelpin, Ingeborg M M van Leeuwen, Sebastiaan A L M Kooijman

Water Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A general model for multiple substrate biodegradation. Application to co-metabolism of structurally non-analogous compounds.
Bernd W Brandt, Ingeborg M M van Leeuwen, Sebastiaan A L M Kooijman

Water Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis